Apolipoprotein al and apolipoprotein B containing particle analysis in normolipidemic hemodialyzed patients: Evidence of free apolipoprotein E

American Journal of Nephrology

Volumn 16, Issue 4, 1996, Pages 287-292

  Kandoussi, Abdel Majid ^a   Hugue, Valérie ^a   Parra, Henri Joseph ^a   Dracon, Michel ^a   Fruchart, Jean Charles ^a   Tacquet, Albert ^a   Cachera, Claude ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Apolipoprotein AI; Apolipoprotein B; Chronic renal failure; Free apolipoprotein E; Hemodialysis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; LIPID;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROIMMUNOASSAY; HEMODIALYSIS; HUMAN; IMMUNOADSORBENT; IMMUNOAFFINITY CHROMATOGRAPHY; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; APOLIPOPROTEINS E; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOELECTROPHORESIS; IMMUNOSORBENT TECHNIQUES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0029885063     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169011     Document Type: Article

References (35)

1. Alaupovic P: The concepts, classification systems and nomenclature of human plasma lipoproteins; in Lewis LA. Opplt JJ (eds): CRC Handbook of Electrophoresis. Boca Raton, CRC Press, 1980, vol I, pp 27-46.
2. Sucnram A, McConathy WJ, Alaupovic P: Evidence for the lipoprotein heterogeneity of human plasma high density lipoproteins isolated bv three different procedures. Lipids 1979; 14: 505-510.
3. Alaupovic P: Conceptual development of the classification systems of plasma lipoproteins. Protides Biol Fluids 1972;19:9-19.
4. Parsy D, Dracon M, Cachera C, Parra HJ, Van-houtte G, Tacquet A, Fruchart JC: Lipoprotein abnormalities in chronic haemodialysis patients. Nephrol Dial Transplant 1988:3:51-56.
5. Brown MS, Goldstein JL: Lipoprotein receptors in the liver: Control signals for plasma cholesterol traffic. J Clin Invest 1983:72:743-747.
6. Agnani G, Bard JM, Candelicr L, Delattrc S, Fruchart JC, Clavey V: Interaction of LpB:E, LpB:CHI, and LpB:CIIl:E lipoproteins with the low density lipoprotein receptor of HeLa cells. Arterioscler Thromb 1991; 11:1021-1029.
7. Mahlcy RW, Hui DY, Innerarity TL, Wcisgra-ber KH: Two independent lipoprotein receptors on hepatic membranes of dog, swine and man: Apo B, E and apo E receptors. J Clin Invest 1981;68:1197-1206.
8. Reichl D, Miller NE: Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 1989:9:785-797.
9. Betard C, Vu-Dac N, Mezdour H, Ncstruck AC, Leroy A, Fruchart JC: Standardization of an enzymometric assay for apolipoprotein AI by using mixtures of monoclonal antibodies. J Clin Biochem 1987;25:893-899.
10. Fievct C, Koffigan M, Ouvry D, Marcovina S, Moschetlo Y, Fruchart JC: Non-competitive enzyme-linked immunoassay for apoiipopro-tcin B in scrum. Clin Chem 1984:30:98-100.
11. McConathy WJ, Koren E, Wieland H, Campos EM, Lee DM, Kloer HU, Alaupovic P: Evaluation of immunoaffinily chromatography for isolating human lipoproteins containing apolipoprotein B. J Chromatogr 1985;342:47-66.
12. Puchois P, Kandoussi A, Duriez P, McConathy WJ, Fruchart JC, Koren E: Quantitative determination of human plasma apolipoprotein All by a noncompetitive enzyme-linked immunosorbent assay. J Immunoassay 1986;7:285-307.
13. Fruchart JC, Fievct C, Ouvry D, Koffigan M, Beucler I, Ayrault-Jarrier M, Du Barry M, Marcovina S: Enzyme-linked immunoassay on microtiter plates for human apolipoprotein B. Ric Clin Lab 1984;14:569-574.
14. Parsy D, Clavey V, Fievct C, Kora I, Fruchart JC: Quantification of apolipoprotein CII1 in serum by a noncompetitive immunoenzymo-mctric assay. Clin Chem 1985;31:1632-1635.
15. Koffigan M, Kora I, Clavey V, Bard JM, Chapman J, Fruchart JC: Quantification of human apolipoprotein E in plasma and lipoprotein subfractions by a noncompetitive enzyme immunoassay. Clin Chim Acta 1987; 163:245-256.
16. Delpierre C, Fievet C, Equagoo V, Mezdour H, Cachera C, Gesquiere JC, Tartar A, Fruchart JC: Antibodies of predetermined specificity to apolipoprotein CI1 elicited with a synthetic peptide. J Immunol Methods 1988;109:61-68.
17. Kjarvig Broe M, Ingild A: Amplification of immunoprccipitates in agarose gels by horseradish peroxidase-labelled antibody. Scand J Immunol 1983; 17(suppl 10):255-258.
18. Marz W, Gross W: Immunochemical evidence for the presence in human plasma of lipoproteins with apolipoprotein All as the major protein constituent. Biochim Biophvs Acta 1988: 962:155-158.
19. Weisgraber KH, Mahlcy RW: Apoprotein (E-AII) complex of human plasma lipoproteins. J Biol Chem 1978;253:6281-6288.
20. Attman PO, Alaupovic P, Gustafson A: Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int 1987:32:368-375.
21. Nestcl PJ, Fidge NH, Tan MH: Increased lipoprotein remnant formation in chronic renal failure. N Engl J Med 1982;307:329-333.
22. Ron D, Oren I, Aviram M, Better OS, Brook JG: Accumulation of lipoprotein remnants in patients with chronic renal failure. Atherosclerosis 1983;46:67-75.
23. Norbcck HE, Carlson LA: Increased frequency of late pre-P lipoproteins (Lpp) in isolated serum very low density lipoproteins in uremia. Eur J Clin Invest 1980;10:423-4236.
24. Strober W, Waldmann TA: The role of the kidney in the metabolism of plasma proteins. Nephron 1974;13:35-66.
25. Glass CK, Pittman RC, Keller GA, Steinberg D: Tissue sites of apoprotein degradation in the rat. J Biol Chem 1983;258:7161-7167.
26. Fielding CJ, Fröhlich J, Moser K, Fielding PE: Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransfcrase deficiency. Metabolism 1982:31: 1023-1028.
27. Guamieri GF, Moracchicllo M, Campanacci L: Lecithin-cholesterol acyl-lransferase (LCAT) activity in chronic uremia. Kidney Int 1978; 13(suppl 8):26-30.
28. McLeod R, Reeve CE, Fröhlich J: Plasma lipoproteins and lecithinxholesterol acyltransfcr-asc distribution in patients on dialysis. Kidney Int 1984;25:683-688.
29. Glomset JA: The plasma iccithinxholcstcrol acyltransfcrase reaction. J Lipid Res 1968:9: 155-167.
30. Chajck T, Fielding CJ: Isolation and characterization of human serum cholesteryl ester transfer protein. Proc Natl Acad Sci USA 1978:75: 3445-3449.
31. Castro GR, Fielding CJ: Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholestcrolcmic plasma and for the origin of unassociated apoli-poprotcin E (LpE). J Lipid Res 1984;27:58-67.
32. Huang Y, Eckardstein AV, Wu S, Maeda N, Assmann G: A plasma lipoprotein containing only apolipoprotein E and with y mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci USA 1994:91:1834-1838.
33. Ncstruck AC, Niedmann PD, Wieland H, Seidel D: Chromatol'ocusing of human high-dcnsi-ty lipoproteins and isolation of lipoproteins A and AI. Biochim Biophys Acta 1983:753:65-73.
34. Gibson JC, Rubinstein A, Ngai N, Ginsberg HN, Le NA, Gordon RE, Goldberg IJ, Brown WV: Immunoaffinity isolation of apolipopro-tein E containing lipoproteins. Biochim Bio-physActa 1985;835:113-123.
35. Cheung MC, Albers JJ: Characterization of lipoprotein particles isolated by immunoaffinity chromatography: Particles containing AI and All and particles containing AI but not All. J Biol Chem 1984;259:12201-12209.